ClinicalTrials.Veeva

Menu

A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care

Sobi logo

Sobi

Status

Completed

Conditions

Haemophilia B
Haemophilia A

Study type

Observational

Funder types

Industry

Identifiers

NCT02049099
Sobi.HAEM89-001

Details and patient eligibility

About

To describe the current treatment practice during 12 months for previously treated patients diagnosed with haemophilia A or haemophilia B.

Full description

The study population consists of patients with a diagnosis of ICD10: haemophilia A D66.9 or haemophilia B D67.9.

Enrollment

1,658 patients

Sex

Male

Ages

2+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male patients with severe or moderate haemophilia A or haemophilia B.
  • Treatment with Factor VIII/Factor IX products initiated at least 24 months before inclusion in the study.
  • Informed consent is obtained from the patient or patient's legal representative (as applicable according to legal regulation).

Exclusion criteria

  • Confirmed positive inhibitor test detected in the past 24 months.

Trial contacts and locations

12

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems